1-7 of 7
Antonios Douros
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study

Jenny Dimakos, Ying Cui, Robert W. Platt, Christel Renoux, Kristian B. Filion, Antonios Douros
Journal: Diabetes Care
Diabetes Care 2023;46(2):377–383
https://doi.org/10.2337/dc22-1584
Published: 16 December 2022
View articletitled, Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study
Open the PDF for Concomitant Use of Sulfonylureas and β-Blockers and the Risk of Severe Hypoglycemia Among Patients With Type 2 Diabetes: A Population-Based Cohort Study in another window
Journal Articles

Concomitant Use of Sulfonylureas and Warfarin and the Risk of Severe Hypoglycemia: Population-Based Cohort Study

Jenny Dimakos, Ying Cui, Robert W. Platt, Christel Renoux, Kristian B. Filion, Antonios Douros
Journal: Diabetes Care
Diabetes Care 2022;45(10):e131–e133
https://doi.org/10.2337/dc21-2383
Published: 19 August 2022
View articletitled, Concomitant Use of Sulfonylureas and Warfarin and the Risk of Severe Hypoglycemia: Population-Based Cohort Study
Open the PDF for Concomitant Use of Sulfonylureas and Warfarin and the Risk of Severe Hypoglycemia: Population-Based Cohort Study in another window
Journal Articles

Sodium–Glucose Cotransporter 2 Inhibitors and the Risk of Below-Knee Amputation: A Multicenter Observational Study

Oriana Hoi Yun Yu, Sophie Dell’Aniello, Baiju R. Shah, Vanessa C. Brunetti, Jean-Marc Daigle, Michael Fralick, Antonios Douros, Nianping Hu, Silvia Alessi-Severini, Anat Fisher, Shawn C. Bugden, Paul E. Ronksley, Kristian B. Filion, Pierre Ernst, Lisa M. Lix, Canadian Network for Observational Drug Effect Studies (CNODES) Investigators, Samy Suissa, Colin R. Dormuth, Brenda R. Hemmelgarn, Jacqueline Quail, Dan Chateau, J. Michael Paterson, Jacques LeLorier, Adrian R. Levy, Pierre Ernst, Kristian B. Filion, Lisa M. Lix, Robert W. Platt, Ingrid S. Sketris
Journal: Diabetes Care
Diabetes Care 2020;43(10):2444–2452
https://doi.org/10.2337/dc20-0267
Published: 05 August 2020
View articletitled, Sodium–Glucose Cotransporter 2 Inhibitors and the Risk of Below-Knee Amputation: A Multicenter Observational Study
Open the PDF for Sodium–Glucose Cotransporter 2 Inhibitors and the Risk of Below-Knee Amputation: A Multicenter Observational Study in another window
Journal Articles

Sodium–Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes

Devin Abrahami, Antonios Douros, Hui Yin, Oriana H.Y. Yu, Laurent Azoulay
Journal: Diabetes Care
Diabetes Care 2019;42(9):e150–e152
https://doi.org/10.2337/dc19-0849
Published: 11 July 2019
View articletitled, Sodium–Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes
Open the PDF for Sodium–Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes in another window
Journal Articles

Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes

Antonios Douros, Julie Rouette, Hui Yin, Oriana Hoi Yun Yu, Kristian B. Filion, Laurent Azoulay
Journal: Diabetes Care
Diabetes Care 2019;42(8):1496–1503
https://doi.org/10.2337/dc19-0409
Published: 10 June 2019
View articletitled, Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes
Open the PDF for Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes in another window
Includes: Supplementary data
Journal Articles

Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy

Antonios Douros, Kristian B. Filion, Hui Yin, Oriana Hoi Yu, Mahyar Etminan, Jacob A. Udell, Laurent Azoulay
Journal: Diabetes Care
Diabetes Care 2018;41(11):2330–2338
https://doi.org/10.2337/dc17-2280
Published: 27 August 2018
View articletitled, Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy
Open the PDF for Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy in another window
Includes: Supplementary data
Journal Articles

Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events

Antonios Douros, Hui Yin, Oriana Hoi Yun Yu, Kristian B. Filion, Laurent Azoulay, Samy Suissa
Journal: Diabetes Care
Diabetes Care 2017;40(11):1506–1513
https://doi.org/10.2337/dc17-0595
Published: 01 September 2017
View articletitled, Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events
Open the PDF for Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events in another window
Includes: Supplementary data